reticulocyte

Reticulocytes are the immediate precursors to mature erythrocytes, released from bone marrow into peripheral blood, where they mature into RBCs within 1-2 days. They lack a nucleus but retain residual ribosomal RNA, which can be visualized with supravital stains (e.g., new methylene blue or cresyl violet) as a reticular/networked pattern, giving them their name. Normal reticulocyte count is approximately 0.5-1.5% of total RBCs.

Clinically, the reticulocyte count is essential in the workup of anemia to distinguish between hypoproliferative (inadequate marrow response) and hyperproliferative (compensatory marrow response) causes. An elevated reticulocyte count (reticulocytosis) suggests appropriate bone marrow response to peripheral RBC loss or destruction, as seen in hemolytic anemias (e.g., sickle cell disease, G6PD deficiency, autoimmune hemolytic anemia) or acute blood loss. A low reticulocyte count in the setting of anemia suggests bone marrow failure or hypoproliferation, as seen in iron deficiency anemia, anemia of chronic disease, aplastic anemia, or bone marrow infiltrative processes.

The corrected reticulocyte count (CRC) adjusts for the degree of anemia: CRC = reticulocyte count (%) × (patient's Hct/normal Hct). The reticulocyte production index (RPI) further corrects for the longer maturation time of reticulocytes released prematurely in anemia. An RPI >2-3 indicates adequate marrow response (hemolysis or blood loss), while RPI <2 indicates inadequate marrow response (production defect).

Elevated reticulocyte counts are also seen after treatment of nutritional deficiencies (e.g., iron, B12, folate supplementation), termed a 'reticulocyte spike' or reticulocytosis response, which confirms appropriate treatment response.